Edwards Lifesciences
1,090 hedge funds and large institutions have $40.3B invested in Edwards Lifesciences in 2019 Q4 according to their latest regulatory filings, with 196 funds opening new positions, 350 increasing their positions, 358 reducing their positions, and 54 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
1% less call options, than puts
Call options by funds: $259M | Put options by funds: $261M
2% less repeat investments, than reductions
Existing positions increased: 350 | Existing positions reduced: 358
3% less funds holding in top 10
Funds holding in top 10: 30 → 29 (-1)
Holders
1,090
Holding in Top 10
29
Calls
$259M
Puts
$261M
Top Buyers
| 1 | +$385M | |
| 2 | +$159M | |
| 3 | +$143M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$127M |
| 5 |
Two Sigma Investments
New York
|
+$123M |
Top Sellers
| 1 | -$310M | |
| 2 | -$285M | |
| 3 | -$222M | |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
-$200M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$117M |